Neil Woodford drops biotech, buys BT, IMB, IAG – is he right?

Is Neil Woodford’s switch from risky small caps to these three FTSE 100 dividend payers a stunning return to form, or a harbinger of doom for your portfolio?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Neil Woodford was once considered the UK’s answer to Warren Buffett. The one-time golden boy of fund managers saw his star crash and burn after his flagship £3.7bn Woodford Equity Income Fund was suspended in June 2019.

In details published by Woodford Investment Management, the fallen idol revealed he has sold off risky AI and biotech stocks, using 84% of the proceeds to pile money into proven FTSE 100 dividend payers BT (LSE:BT.A), tobacco giant Imperial Brands (LSE:IMB) and International Consolidated Airlines (LSE:IAG).

It seems Woodford has gone back to the drawing board to follow advice that Buffett and Terry Smith have been plugging for years: buy good, long-term companies at attractive valuations.

While the celebrated stock-picker’s reputation may never recover, is he actually right this time?

Give me a call

BT looks undervalued to me. The telecoms giant has been on my watchlist for a while and now it could be at a decent price to jump in, with shares down 14% last month and a cheap trailing price-to-earnings (P/E) ratio of 6.7.

The market tends to expect a lot, and when an August trading update showed a 1% revenue drop, the market started pouting and had a bit of a tantrum.

But City analysts think earnings will grow 7.6% next year. I’d also back the EE owner to make significant gains off the back of the first 5G mobile network in the UK.

A headline dividend yield of 8.7% is also pretty stellar. I wouldn’t be surprised if BT trimmed this high dividend back to free up more cash for its full fibre broadband rollout but CEO Philip Jansen has this one in hand, I reckon.

Flight to safety

A couple of months back, when the now sadly departed Thomas Cook share price was on the wane, I backed IAG as a much better alternative for investors.

There’s no doubt the British Airways owner will benefit from the highly publicised collapse of its rival.

Dividends are hitting 5.7% right now and past payouts have been covered almost four times by earnings. The shares are a little more expensive than in the summer but still really very cheap at a trailing P/E of 4. Net profit margins of 11.8% across the group are reasonable, although free cash flow is underwater for the year.

Still, the IAG share price is ticking back to levels not seen since early July, so I’d say Woodford has this one right.

Up in smoke

Imperial Brands might seem like an odd pick. In June 2019 CEO Alison Cooper tore up a key company pledge on dividend growth. Before that, IMB had one of the most stellar records on the Footsie, pushing payouts higher by double digits for 18 of the last 20 years. But a headline dividend yield of 8% or more this year is still very good.

IMB isn’t expensive, either. It has a trailing P/E ratio of 7.9 and with earnings expected to grow by 10p a share next year, a forward P/E ratio of 7.5.

Watch out for vaping problems to hit the business hard, though. With declining numbers of smokers worldwide, tobacco firms have invested heavily in e-cigarettes. India just banned the smokeless cartridges and several US states have banned vaping too. This kind of public health outcry could spread, which would hurt sales badly.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Tom Rodgers owns no shares mentioned. The Motley Fool UK has recommended Imperial Brands. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »